For instance, mutations in the interleukin-6 receptor (IL-6R) within the brains of depression patients can lead to the activation of IL-6 trans-signaling pathway, subsequently triggering neuroinflammation and psychiatric disorders [23,36]. Here, IL6R is linked to depressive symptom measurement.